Clinical Trial Update: Efficacy of a New Symbiotic Formulation in Children With Familial Hypercholesterolemia [Phase 1, Phase 2]

View source ↗

Summary

This trial update reports on the efficacy results from Phase 1/2 studies of a new symbiotic formulation in children with familial hypercholesterolemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Familial Hypercholesterolemia

Drugs mentioned

• New symbiotic formulation

Snippet

Sponsor: Federico II University | Conditions: Dyslipidemia, Familial Hypercholesterolemia | Phase 1, Phase 2 | Status: COMPLETED